These controversial results about Notch in leukemia demand for better understanding of the mechanisms that contribute to Notch signaling in leukemia in order to develop novel strategies to inhibit Notch1 signaling with alternative mechanism different from GSIs as potential promising approaches for T-ALL therapy. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.